Back to results
US 2010/0136097 A1Published application
Systems for modulating inflammation
AssigneeSearete LLC, a limited liability corporation of the State of Delaware
InventorsRoderick A. Hyde, Stephen L. Malaska, Elizabeth A. Sweeney, Lowell L. Wood, JR.
Life of this patent
Estimating the term…
Abstract
Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, devices, and systems that modulate at least one inflammatory response or reaction. According to various embodiments, the compositions, methods, devices, and systems relate to modulating one or more of Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes.
Claims26
A system comprising:
- at least one drug delivery device configured to retain and dispense at least one therapeutic composition to at least one subject;
- and
- one or more instructions that when executed on a computing device cause the computing device to
- regulate dispensing of the at least one drug delivery device,
- wherein the delivery device includes at least one therapeutic composition including at least one first agent configured to modulate the activity of one or more NF-kB molecules;
- and
- at least one second agent configured to modulate the activity of one or more Src family kinases.
4 more elements
Dependencies are inferred from the claim text.